Stimulated γδ T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+Breast Cancer-Reference-Cited by-同舟云学术

Stimulated γδ T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+Breast Cancer

Published:2011-06-13 Issue:2 Volume:187 Page:1031-1038
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Capietto Aude-Hélène,Martinet Ludovic,Fournié Jean-Jacques

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference71 articles.

1. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

2. Humanization of an anti-p185HER2 antibody for human cancer therapy.

3. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.;Baselga;Cancer Res.,1998

4. First-Line Herceptin^® Monotherapy in Metastatic Breast Cancer

5. Health-related quality of life in women with metastatic breast cancer treated with trastuzumab (Herceptin).;Osoba;Semin. Oncol.,1999

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-Depth Analysis of the Peripheral Immune Profile of HER2+ Breast Cancer Patients on Neoadjuvant Treatment with Chemotherapy Plus Trastuzumab Plus Pertuzumab;International Journal of Molecular Sciences;2024-08-27

2. Potential of gamma/delta T cells for solid tumor immunotherapy;Frontiers in Immunology;2024-08-26

3. Directing the migration of serum-free, ex vivo-expanded Vγ9Vδ2 T cells;Frontiers in Immunology;2024-02-29

4. Update on current and new potential immunotherapies in breast cancer, from bench to bedside;Frontiers in Immunology;2024-02-15

5. Development of Innate-Immune-Cell-Based Immunotherapy for Adult T-Cell Leukemia–Lymphoma;Cells;2024-01-10